Pembrolizumab-Axitinib Versus Nivolumab-Cabozantinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Real-World Comparison (Aron-1)

AuthID
P-018-YCN
36
Author(s)
Santoni, M
·
Roviello, G
·
Grande, E
·
De Giorgi, U
·
Fiala, O
·
Seront, E
·
Molina-Cerrillo, J
·
Pichler, R
·
Myint, ZW
·
Kucharz, J
·
[+3]·
[+13]·
Bhuva, D
·
Catalano, M
·
Vau, N
·
Kopp, RM
·
Buti, S
·
Bamias, A
·
Porta, C
·
Sunela, K
·
Massari, F
Tipo de Documento
Article
Year published
2025
Publicado
in CANCER IMMUNOLOGY IMMUNOTHERAPY, ISSN: 0340-7004
Volume: 74, Número: 7
Indexing
Publication Identifiers
Pubmed: 40423789
SCOPUS: 2-s2.0-105006814776
Wos: WOS:001497901100002
Source Identifiers
ISSN: 0340-7004
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Santoni, M;   2 Roviello, G;   3 Grande, E;
4 De Giorgi, U;   5 Fiala, O;   6 Seront, E;
7 Molina-Cerrillo, J;   8 Pichler, R;   9 Myint, ZW;
10 Kucharz, J;   11 Kanesvaran, R;   12 Buettner, T;
13 Pichler, M;   14 Basso, U;   15 Kopecky, J;
16 Bourlon, MT;   17 Cerbone, L;   18 Buchler, T;
19 Pinto, A;   20 de Liaño, AG;   21 Gianni, C;
22 Zgura, A;   23 Rescigno, P;   24 Ansari, J;
25 Caffo, O;   26 Kueronya, Z;   27 Vitale, MG;
28 Bhuva, D;   29 Catalano, M;   30 Vau, N;
31 Kopp, RM;   32 Buti, S;   33 Bamias, A;
34 Porta, C;   35 Sunela, K;   36 Massari, F;